Soft-tissue sarcomas: Overview of management, with a focus on surgical treatment considerations.
about
Pazopanib in the treatment of soft tissue sarcomaManagement and prevention of recurrent paratesticular liposarcomaClinical outcomes and safety with trabectedin therapy in patients with advanced soft tissue sarcomas following failure of prior chemotherapy: results of a worldwide expanded access program study.Epidemiology, treatment patterns, and outcomes of metastatic soft tissue sarcoma in a community-based oncology network.Soft tissue sarcoma in the dog - Part 2: surgical margins, controversies and a comparative review.Soft tissue sarcoma in the dog - part 1: a current review.Lower extremity mass.A retrospective statistical analysis of high-grade soft tissue sarcomas.
P2860
Q28269229-622FA800-6569-4E45-B14C-BD74FD4C168AQ34371800-2CD99A68-A2C0-498C-8750-F1EB18AD1F33Q34647970-BC0D1794-BC54-4E88-8E09-4EBDEF2FC898Q37616621-1C307B44-3D0A-4D76-A574-C9319C7CF1A2Q38761697-32422CE1-B687-49E1-9B8C-54A2EA1ACEC6Q38953742-F8F62578-BC2E-4E02-A84C-A541B7864B24Q42927966-AEE913E6-A4E1-4074-877C-2ED278F1028BQ43504845-439DE45F-87EC-40B8-A5D1-764ED0A02CE6
P2860
Soft-tissue sarcomas: Overview of management, with a focus on surgical treatment considerations.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Soft-tissue sarcomas: Overview ...... ical treatment considerations.
@en
Soft-tissue sarcomas: Overview ...... ical treatment considerations.
@nl
type
label
Soft-tissue sarcomas: Overview ...... ical treatment considerations.
@en
Soft-tissue sarcomas: Overview ...... ical treatment considerations.
@nl
prefLabel
Soft-tissue sarcomas: Overview ...... ical treatment considerations.
@en
Soft-tissue sarcomas: Overview ...... ical treatment considerations.
@nl
P356
P1476
Soft-tissue sarcomas: Overview ...... ical treatment considerations.
@en
P2093
Steven A Lietman
P356
10.3949/CCJM.77.S1.03
P478
77 Suppl 1
P577
2010-03-01T00:00:00Z